Steven R. Smith, MD, AdventHealth’s chief scientific officer discussed AdventHealth Translational Research Institute’s decade of discovery in Central Florida on a recent webinar with the Florida Medical Association. “I’ve never been more optimistic about the state of biomedical science and medical science than I am right now,” Smith said.
Smith, who has overseen TRI since its inception, explained the medical research currently taking place, and where the Translational Research Institute (TRI), is headed. “We feel an obligation to conduct research. We want to learn from our patients so we can improve the care we provide them,” Smith said.
TRI’s mission is to extend and improve the quality of lives by conducting world-class, innovative translational research that leads to discoveries and ultimately cures for obesity, diabetes and cardiovascular diseases. Over the past 10 years, TRI researchers have conducted more than 200 studies and produced more than 350 peer reviewed, published works that have helped to advance medicine. Smith explained, “To define it simply, translation is bedside to bench. We’re going to study human biology with cells, tissue and DNA and then we’re going to relate that back to the human condition.”
During the conversation, Smith spoke about the importance of collaboration and innovation in research and answered questions from viewers.
You can watch the webinar by clicking play below:
Before the webinar, FMA invited Smith to talk about why TRI is unique, its milestones and what excited him most about the work being done there. Click here to read that article.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Celebration Team Performs First-in-World Procedure Targeting Kidney Tumor with Sound Beams
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
Podcast
Test Apple Podcast - All Episodes
Test Apple Podcast
Social Media Post
AdventHealthMD Social Media Post Test - Consumer Title
As the Official Healthcare Provider of the 2024 NASCAR Chicago Street Race, we’re thrilled to support such a memorable experience with this amazing community.
News
Clone of AdventHealth Celebration Team Performs First-in-world Procedure Targeting Kidney Tumor with Sound Beams
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Media Coverage
Consumer Title - AdventHealthMD Media Coverage Test
A summary of the article goes here. A summary of the article goes here. A summary of the article goes here. A summary of the article goes here.
News
AdventHealth Celebration Team Performs First-in-world Procedure Targeting Kidney Tumor with Sound Beams
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Video
Dr. Corbin on the gut microbiome research study
Dr. Corbin on the gut microbiome research study
News
Genetic Testing at AdventHealth Alerts Woman, Doctors to Aggressive Cancer Before it Develops
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
News
AdventHealth Clinical Research Unit Recruiting Patients with Solid Tumors Harboring MTAP Deletion for Phase I Clinical Trial
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
News
AdventHealth Research Institute conducting two studies on the impact of shift work on healthcare workers’ health
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
News
AdventHealth Celebration Successfully Performs First Robotics-assisted Cochlear Implant Procedure in Florida with the iotaSOFT® Insertion System.
In January 2024, AdventHealth Celebration neurotologist Michael Seidman, MD, FACS, became the first in Florida and the Southeast to complete a robotics-assisted cochlear implant procedure using the...
News
New England Journal of Medicine highlights Guru Sonpavde, MD’s work in new immunotherapy-chemotherapy combination improving survival for patients with advanced urothelial carcinoma
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...